Spanish expert consensus on the use of safinamide in Parkinson's disease

Spanish expert consensus on the use of safinamide in Parkinson's disease

Safinamide is a new add-on drug to levodopa for the treatment of Parkinson's disease (PD) with motor fluctuations. Due to the recent incorporation of safinamide into routine clinical practice, no post-authorisation phase IV studies on the safety of safinamide have been conducted to date. This s...

Full description

Bibliographic Details
Main Authors: F. Valldeoriola, F. Grandas, J.M. Arbelo, M. Blázquez Estrada, M. Calopa Garriga, V.M. Campos-Arillo, P.J. Garcia Ruiz, J.C. Gómez Esteban, C. Leiva Santana, J.C. Martínez Castrillo, P. Mir, A. Salvador Aliaga, F. Vivancos Matellano, R.M. Yáñez Baña
Format: Article
Language:English
Published: Elsevier España 2021-11-01
Series:Neurología (English Edition)
Subjects:
Parkinson
Safinamida
Inhibidores de la MAO
Fluctuaciones
Discinesias
Glutamato
Online Access:http://www.sciencedirect.com/science/article/pii/S2173580820300924

Internet

http://www.sciencedirect.com/science/article/pii/S2173580820300924

Similar Items